These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6429272)

  • 1. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
    Kramer BS; Elfenbein GJ
    J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
    [No Abstract]   [Full Text] [Related]  

  • 2. What is graft versus host disease?
    van Bekkum DW
    Bone Marrow Transplant; 1991; 7 Suppl 2():110-1. PubMed ID: 1878668
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation. III. Major problems and future directions.
    Spruce WE
    Am J Pediatr Hematol Oncol; 1983; 5(3):301-6. PubMed ID: 6414326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reconstitution of cellular immunity after bone marrow transplantation in children.
    Lanfranchi A; Porta F; Locatelli F; Zecca M; Nespoli L; Albertini A
    Haematologica; 1992; 77(4):336-47. PubMed ID: 1427444
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation: from last resort to preferred therapy.
    Jansen J; Provisor AJ; Vaughan J; Hoffman R
    Indiana Med; 1985 Apr; 78(4):265-9. PubMed ID: 3923097
    [No Abstract]   [Full Text] [Related]  

  • 6. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
    Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
    Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Posttransfusion graft vs host disease].
    Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
    Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation.
    Nuscher R; Baltzer L; Repinec DA; Almquist G; Barrett JE; LaBombardi S; DeMao JD; Diver ME; Field BA; Lee MC
    Am J Nurs; 1984 Jun; 84(6):764-72. PubMed ID: 6375375
    [No Abstract]   [Full Text] [Related]  

  • 9. The paradox of the bone-marrow graft in the immunologically deficient host.
    Billingham RE; Streilein JW
    N Engl J Med; 1971 Nov; 285(19):1081-3. PubMed ID: 4106200
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency following human marrow transplantation: in vitro studies.
    Neely JE; Neely AN; Kersey JH
    Transplant Proc; 1978 Mar; 10(1):229-31. PubMed ID: 345562
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there an effective therapy for chronic graft-versus-host disease?
    Schiller G; Gale RP
    Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
    [No Abstract]   [Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects after allogeneic bone marrow transplantation.
    Dicke KA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S11-3. PubMed ID: 7728118
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation in pediatrics.
    Abramowsky CR; Coccia PF
    Perspect Pediatr Pathol; 1989; 13():6-43. PubMed ID: 2697854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Graft versus host disease: the most threatening complication of bone marrow transplant. Review of the literature].
    Rasero L; Bonavita K; Marsullo M
    Assist Inferm Ric; 2002; 21(4):211-21. PubMed ID: 12674033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Allogeneic bone marrow graft in children].
    Fischer A; Griscelli C
    Arch Fr Pediatr; 1986 Jan; 43(1):3-8. PubMed ID: 3085626
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious complications of bone marrow transplantation.
    Winston DJ; Ho WG; Champlin RE; Gale RP
    Exp Hematol; 1984 Mar; 12(3):205-15. PubMed ID: 6368256
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
    Fay JW; Nash RA; Wingard JR; Przepiorka D; Collins RH; Anasetti C; Devine SM; Piñeiro LA; Storb RF; Aro RM
    Transplant Proc; 1995 Feb; 27(1):1374. PubMed ID: 7533383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.